The convergence of Quantum Computing, AI, and real-world data across Neuroscience, Genomics & Drug Discovery, and Quantitative Finance
Neurotech ($8B by 2027), Genomics AI ($50B by 2030), and Quant Finance ($140B+) — all accessible through one unified quantum digital twin platform
QVM (Mind), QVO (Cell), and QVF (Markets) — each a specialized quantum digital twin engine built on a unified theoretical foundation, optimized for domain-specific complexity
The only platform delivering quantum digital twins across biology, mind, and markets from a single peer-reviewed theoretical foundation
Mental health diagnostics, closed-loop neuromodulation, cognitive enhancement, BCI decoding
Quantum virtual cell models for cancer, rare diseases, ADMET profiling, and combination therapy design
Portfolio inversion, regime detection, quantum market state analysis, systemic risk modeling
Multi-agent Hamiltonian design, agentic quantum simulation, HAHD orchestration pipeline